Anti-MT1G/ MT1/ MT1K functional antibody

Anti-MT1G/ MT1/ MT1K functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to MT1G/MT1G products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1484-Ab-1/ GM-Tg-hg-SE1484-Ab-2Anti-Human MT1G monoclonal antibodyHuman
GM-Tg-rg-SE1484-Ab-1/ GM-Tg-rg-SE1484-Ab-2Anti-Rat MT1G monoclonal antibodyRat
GM-Tg-mg-SE1484-Ab-1/ GM-Tg-mg-SE1484-Ab-2Anti-Mouse MT1G monoclonal antibodyMouse
GM-Tg-cynog-SE1484-Ab-1/ GM-Tg-cynog-SE1484-Ab-2Anti-Cynomolgus/ Rhesus macaque MT1G monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1484-Ab-1/ GM-Tg-felg-SE1484-Ab-2Anti-Feline MT1G monoclonal antibodyFeline
GM-Tg-cang-SE1484-Ab-1/ GM-Tg-cang-SE1484-Ab-2Anti-Canine MT1G monoclonal antibodyCanine
GM-Tg-bovg-SE1484-Ab-1/ GM-Tg-bovg-SE1484-Ab-2Anti-Bovine MT1G monoclonal antibodyBovine
GM-Tg-equg-SE1484-Ab-1/ GM-Tg-equg-SE1484-Ab-2Anti-Equine MT1G monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1484-Ab-1/ GM-Tg-hg-SE1484-Ab-2; GM-Tg-rg-SE1484-Ab-1/ GM-Tg-rg-SE1484-Ab-2;
GM-Tg-mg-SE1484-Ab-1/ GM-Tg-mg-SE1484-Ab-2; GM-Tg-cynog-SE1484-Ab-1/ GM-Tg-cynog-SE1484-Ab-2;
GM-Tg-felg-SE1484-Ab-1/ GM-Tg-felg-SE1484-Ab-2; GM-Tg-cang-SE1484-Ab-1/ GM-Tg-cang-SE1484-Ab-2;
GM-Tg-bovg-SE1484-Ab-1/ GM-Tg-bovg-SE1484-Ab-2; GM-Tg-equg-SE1484-Ab-1/ GM-Tg-equg-SE1484-Ab-2
Products NameAnti-MT1G monoclonal antibody
Formatmab
Target NameMT1G
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MT1G benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1484-Ag-1Recombinant multi-species MT1G/ MT1/ MT1K protein
    ORF Viral VectorpGMLP001819human MT1G Lentivirus plasmid
    ORF Viral VectorvGMLP001819human MT1G Lentivirus particle


    Target information

    Target IDGM-SE1484
    Target NameMT1G
    Gene ID4495
    Gene Symbol and SynonymsMT1,MT1G,MT1K
    Uniprot AccessionP13640
    Uniprot Entry NameMT1G_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000125144
    Target ClassificationTumor-associated antigen (TAA)

    The target: MT1G, gene name: MT1G, also named as MT1, MT1K. Enables zinc ion binding activity. Involved in cellular response to metal ion; cellular response to vascular endothelial growth factor stimulus; and negative regulation of growth. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.